Press Releases July 29, 2026 07:30 AM

OptimizeRx Sets Second Quarter 2026 Conference Call for August 12, 2026, at 4:30 p.m. ET

OptimizeRx Announces Second Quarter 2026 Earnings Conference Call Scheduled for August 12, 2026

By Sofia Navarro
Share
Twitter Reddit Facebook LinkedIn
OPRX

OptimizeRx Corp., a healthcare technology company specializing in connecting life sciences brands with healthcare professionals and patients, will hold its Q2 2026 earnings call on August 12, 2026. The company aims to discuss its financial results for the period ended June 30, 2026, following the issuance of a detailed press release.

OptimizeRx Sets Second Quarter 2026 Conference Call for August 12, 2026, at 4:30 p.m. ET
OPRX
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • OptimizeRx provides AI-driven healthcare marketing solutions facilitating engagement between life science brands, healthcare professionals, and patients.
  • The company is scheduled to release Q2 2026 financial results and hold a conference call to discuss performance and answer investor questions.
  • OptimizeRx emphasizes privacy-safe, patient-centric technology designed to improve healthcare outcomes by targeting marketing efforts effectively.

WALTHAM, Mass., July 29, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients at the most important decision points, will hold a conference call on Wednesday, August 12, 2026, at 4:30 p.m. Eastern Time to discuss its results for the second quarter period ended June 30, 2026. The financial results will be issued in a press release prior to the call.

OptimizeRx management will host the call, followed by a question-and-answer period. Details for the conference call can be found below:

Date: Wednesday, August 12, 2026 Time: 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) Toll Free: 1-877-407-9716International: 1-201-493-6779Conference ID: 13761843Call me™ Link: https://callme.viavid.com/viavid/?callme=true&passcode=13760191&h=true&info=company-email&r=true&B=6Webcast: https://viavid.webcasts.com/starthere.jsp?ei=1770269&tp_key=7d483832d3  

Please call the conference telephone number or log on to the web access link five minutes prior to the start time.

A replay of the call will remain available for 12 months via the investors section of the OptimizeRx website at https://investors.optimizerx.com/.

About OptimizeRx

OptimizeRx is a leading healthcare technology company that’s redefining how life science brands connect with patients and healthcare providers. Our platform combines innovative AI-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver timely, relevant, and hyper-local engagement. By bridging the gap between HCP and DTC strategies, we empower brands to create synchronized marketing solutions that drive faster treatment decisions and improved patient outcomes.

Our commitment to privacy-safe, patient-centric technology ensures that every interaction is designed to make a meaningful impact, delivering life-changing therapies to the right patients at the right time. Headquartered in Waltham, Massachusetts, OptimizeRx partners with some of the world’s leading pharmaceutical and life sciences companies to transform the healthcare landscape and create a healthier future for all.

For more information, follow the Company on LinkedIn or X, or visit www.optimizerx.com.

OptimizeRx Contact
Andy D’Silva, Chief Business Officer
[email protected]

Investor Relations Contact
Douglas Farrell
LifeSci Advisors, LLC
[email protected]


Risks

  • Financial results for Q2 2026 could fall short of market expectations impacting stock price and investor sentiment.
  • Dependence on continued partnerships with pharmaceutical and life sciences companies to maintain revenue growth.
  • Market and regulatory changes in healthcare technology sector could affect operational performance and strategic initiatives.

More from Press Releases

Axe Compute Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Sep 11, 2026 EverCommerce Announces an Increase and Extension of its Share Repurchase Program Sep 11, 2026 Grupo Aeroportuario del Pacifico Announces the Execution of Bank Credit Facilities Totaling Ps. 8,000 Million Sep 11, 2026 Eastern International Ltd. Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency Sep 11, 2026 ArrowMark Financial Corp. Announces Q2 Results and Special Distribution of $0.10 and Monthly Cash Distribution of $0.15 per Share for September 2026 Sep 11, 2026